Professor Jeannette Lechner-Scott wins 2024 MS Research Award

Newcastle’s Professor Jeannette Lechner-Scott, an internationally recognized neurologist and leader in multiple sclerosis (MS) research and clinical care, has been awarded the 2024 MS Research Award by MS Australia.

Novo Holdings acquires Catalent for $16.5bn – Pharmaceutical Technology

Share this article Novo Holdings, the Novo Nordisk Foundation’s holding and investment company, announced plans for a $16.5bn acquisition of Catalent. Credit: NurPhoto / Getty

February 5, 2024

In a world first, Vertex, CRISPR win UK approval for CRISPR-edited therapy to treat sickle cell disease, beta-thalassemia

Vertex and CRISPR Therapeutics have won the first-ever approval for a therapy created with CRISPR gene editing, as the UK drug regulator MHRA greenlights their

November 17, 2023

Pharmalittle: We’re reading about unsupported drug price hikes, an annual HIV prevention shot, and more

Top of the morning to you, and a fine one it is. Clear blue skies and chilly breezes are wafting across the Pharmalot campus, where

December 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.